A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer

被引:2
|
作者
Wang, Guancong [1 ]
Li, Jiasen [2 ]
Huang, Ying [3 ]
Guo, Yincong [1 ]
机构
[1] Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Colorectal & Anal Surg, Zhangzhou 363000, Peoples R China
[2] Fujian Med Univ, ZhangZhou Affiliated Hosp, Dept Intervent Radiol, Zhangzhou, Peoples R China
[3] Fujian Med Univ, Dept Colorectal Surg, Union Hosp, Fuzhou 350001, Peoples R China
来源
CANCER MEDICINE | 2024年 / 13卷 / 11期
关键词
dynamic nomogram; locally advanced rectal cancer; neoadjuvant chemoradiotherapy; pathological complete response; total mesorectal excision; MUCINOUS ADENOCARCINOMA; TUMOR RESPONSE; ANAL VERGE; CHEMORADIOTHERAPY; THERAPY; RADIOTHERAPY; PROGNOSIS; DISTANCE; MRI;
D O I
10.1002/cam4.7251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To explore the clinical factors associated with pathologic complete response (pCR) for locally advanced rectal cancer (LARC) patients treated with neoadjuvant chemoradiotherapy (nCRT) and develop a web-based dynamic nomogram. Methods: Retrospective analysis of patients with examination confirmed LARC from 2011 to 2022. Patients from the Union Hospital of Fujian Medical University were included as the training cohort (n = 1579) and Zhangzhou Hospital of Fujian Medical University as the external validation cohort (n = 246). Results: In the training cohort, after nCRT, 350 (22.2%) patients achieved pCR. More stomas were avoided in pCR patients (73.9% vs. 69.7%, p = 0.043). After a median follow-up time of 47.7 months (IQR 2-145) shown OS (5-year: 93.7% vs. 81.0%, HR = 0.310, 95%CI: 0.189-0.510, p < 0.001) and DFS (5-year: 91.2% vs. 75.0%, HR = 0.204, 95%CI: 0.216-0.484, p < 0.001) were significantly better among patients with pCR than non-pCR. Multivariable Logistic analysis shown pCR was significantly associated with Pre-CRT CEA (HR = 0.944, 95%CI: 0.921-0.968; p < 0.001), histopathology (HR = 4.608, 95%CI: 2.625-8.089; p < 0.001), Pre-CRT T stage (HR = 0.793, 95%CI: 0.634-0.993; p = 0.043), Pre-CRT N stage (HR = 0.727, 95%CI: 0.606-0.873; p = 0.001), Pre-CRT MRI EMVI (HR = 0.352, 95%CI: 0.262-0.473; p < 0.001), total neoadjuvant therapy (HR = 2.264, 95%CI: 1.280-4.004; p = 0.005). Meanwhile, the online version of the nomogram established in this study was publicized on an open-access website (URL: ). The model predicted accuracy with a C-index of 0.73 (95% CI: 0.70-0.75), with an average C-index of 0.73 for the internal cross validation and 0.78 (95% CI: 0.72-0.83) for the external validation cohort, showing excellent model accuracy. Delong test results showed the model has an important gain value for clinical characteristics to predict pCR in rectal cancer. Conclusions: Patients with pCR had a better prognosis, including OS and DFS, and were independently associated with Pre-CRT CEA, histopathology, Pre-CRT T/N stage, Pre-CRT MRI EMVI, and TNT. A web-based dynamic nomogram was successfully established for clinical use at any time.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response
    Turner, Megan C.
    Keenan, Jeffrey E.
    Rushing, Christel N.
    Gulack, Brian C.
    Nussbaum, Daniel P.
    Benrashid, Ehsan
    Hyslop, Terry
    Strickler, John H.
    Mantyh, Christopher R.
    Migaly, John
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (08) : 1614 - 1622
  • [42] Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response
    Megan C. Turner
    Jeffrey E. Keenan
    Christel N. Rushing
    Brian C. Gulack
    Daniel P. Nussbaum
    Ehsan Benrashid
    Terry Hyslop
    John H. Strickler
    Christopher R. Mantyh
    John Migaly
    Journal of Gastrointestinal Surgery, 2019, 23 : 1614 - 1622
  • [43] Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy
    Imbriaco, Massimo
    Ponsiglione, Andrea
    RADIOLOGY, 2021, 299 (02) : 301 - 302
  • [44] Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer
    Tong, Tong
    Sun, Yiqun
    Gollub, Marc J.
    Peng, Weijun
    Cai, Sanjun
    Zhang, Zhen
    Gu, Yajia
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2015, 42 (03) : 673 - 680
  • [45] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    MODERN PATHOLOGY, 2022, 35 : 489 - 490
  • [46] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 489 - 490
  • [47] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Ling, Yihong
    Liu, Hailing
    Zou, Xuan
    Wang, Jing
    Huang, Junzhou
    Yun, Jingping
    Yao, Jianhua
    Huang, Yan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 489 - 490
  • [49] Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer
    Ribeiro Jr, Ulysses
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 1945 - 1947
  • [50] Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer
    Ulysses Ribeiro
    Annals of Surgical Oncology, 2023, 30 : 1945 - 1947